CTMX - CytomX slides after early data for Amgen-partnered cancer drug
2024-05-09 11:33:48 ET
More on Amgen, CytomX, etc.
- CytomX Therapeutics, Inc. (CTMX) Q1 2024 Earnings Call Transcript
- Amgen Could Become A Real Contender In The Obesity Market
- Amgen's Q1 Earnings: Solid All Court Progress, Major Weight Loss Catalyst Pending
- CytomX teams up with Merck for CX-801 clinical study
- CytomX raised to buy at Jefferies in anticipation of phase 1 solid tumors asset data